Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 19 of 19 publications.

Pe M, Alanya A, Falk RS, Amdal CD, Bjordal K, Chang J, Cislo P, Coens C, Dirven L, Speck RM, Fitzgerald K, Galinsky J, Giesinger JM, Holzner B, Le Cessie S, O'Connor D, Oliver K, Pawar V, Quinten C, Schlichting M, Ren J, Roychoudhury S, Taphoorn MJB, Velikova G, Wintner LM, Griebsch I, Bottomley A, SISAQOL-IMI Consortium. Setting international standards in analyzing patient-reported outcomes and quality of life endpoints in cancer clinical trials-innovative medicines nitiative (SISAQOL-IMI): stakeholder views, objectives, and procedures. Lancet Oncol. 2023 Jun;24(6):e270-83. doi: 10.1016/S1470-2045(23)00157-2

Delgado-Ortiz L, Carsin AE, Merino J, Cobo I, Koch S, Goldberg X, Chevance G, Bosch de Basea M, Castano-Vinyals G, Espinosa A, Carreras A, Cortes Martinez B, Straif K, de Cid R, Kogevinas M, Garcia-Aymerich J. Changes in population health-related behaviors during a COVID-19 surge: a natural experiment. Ann Behav Med. 2023 Apr 5;57(3):216-26. doi: 10.1093/abm/kaac054

Motzer R, Porta C, Alekseev B, Rha SY, Choueiri TK, Mendez-Vidal MJ, Hong SH, Kapoor A, Goh JC, Eto M, Bennett L, Wang J, Pan JJ, Saretsky TL, Perini RF, He CS, Mody K, Cella D. Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study. Lancet Oncol. 2022 Jun;23(6):768-80. doi: 10.1016/S1470-2045(22)00212-1

Andrews S, Mansfield C, O'Neill C, Peay H. Meaningful treatment outcomes for Sanfilippo syndrome: using a combination of focus groups and best-worst scaling to elicit and explore parents' priorities. Poster presented at the 2019 25th Annual Qualitative Health Research Conference; October 2019. Vancouver, Canada. [abstract] Int J Qual Methods. 2020 Mar 30; 19:2. doi: 10.1177/1609406920909934

Barrows SM, Wright K, Copley-Merriman C, Kaye JA, Chioda M, Wiltshire R, Torgersen KM, Masters ET. Systematic review of sequencing of ALK inhibitors in ALK-positive non-small-cell lung cancer. Lung Cancer. 2019 Feb 8;2019:11-20. doi: 10.2147/LCTT.S179349

Horn L, Bauml J, Forde PM, Davis KL, Myall NJ, Sasane M, Dalal A, Culver K, Wozniak AJ, Baik CS, Mutebi A, Zhang P, Wakelee HA, Johnson BE. Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancer. Lung Cancer. 2019 Feb;128(2019):74-90. doi: 10.1016/j.lungcan.2018.12.003

Andreas S, Chouaid C, Danson S, Siakpere O, Benjamin L, Ehness R, Dramard-Goasdoue MH, Barth J, Hoffmann H, Potter V, Barlesi F, Chirila C, Hollis K, Sweeney C, Price M, Wolowacz S, Kaye JA, Kontoudis I. Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: a retrospective observational study (LuCaBIS). Lung Cancer. 2018 Oct;124:298-309. doi: 10.1016/j.lungcan.2018.06.007

Chouaid C, Danson S, Andreas S, Siakpere O, Benjamin L, Ehness R, Dramard-Goasdoue MH, Barth J, Hoffmann H, Potter V, Barlesi F, Price M, Chirila C, Hollis K, Sweeney C, Wolowacz S, Kaye JA, Kontoudis I. Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness study. Lung Cancer. 2018 Oct;124:310-6. doi: 10.1016/j.lungcan.2018.07.042.

Du XL, Parikh RC, Lairson DR. Racial and geographic disparities in the patterns of care and costs at the end of life for patients with lung cancer in 2007–2010 after the 2006 introduction of bevacizumab. Lung Cancer. 2015 Dec;90(3):442-50.

Davis KL, Goyal RK, Able SL, Brown J, Li L, Kaye JA. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer. Lung Cancer. 2015 Feb;87(2):176-85. doi: 10.1016/j.lungcan.2014.11.002

Cella D, Eton DT, Fairclough DL, Heyes AE, Silberman C, Wolf MK. What is a clinically meaningful change (CMC) on the Functional Assessment of Cancer Therapy - Lung (FACT-L): analysis of ECOG 5592 data. Poster presented at the 7th Central European Lung Cancer Conference; June 2001. Prague, Czech Republic. [abstract] Lung Cancer. 2001 May; 32(Suppl 1):52.

Cella D, Eton DT, Fairclough DL, Heyes AE, Silberman C, Bonomi P, Wolf MK. What is a clinically meaningful change (CMC) on the Functional Assessment of Cancer Therapy (lung) (FACT-L): analysis of ECOG 5592 data. Lung Cancer. 2001;373-6.

King TK, Britt DM, Day A. Changes in body esteem and sexual satisfaction in obese females enrolled in a weight loss program. Ann Behav Med. 2001;23(Suppl):S023.

King TK, Britt DM, Lloyd E. Demographic and psychological characteristics of obese smokers presenting for weight loss treatment. Ann Behav Med. 2001;23(Suppl):S027.

Britt (DiBenedetti) DM, Seaton M, Cohan LM, Collins FL. Cigarette smoking and chewing gum: response to a laboratory-induced stressor. Poster presented at the Association for the Behavioral Sciences and Medical Education Conference; 1999. [abstract] Ann Behav Med. 1999; 21(Suppl):S039.

Cohen LM, Britt (DiBenedetti) DM, Collins FL, al’Absi M. A multimodal assessment of the effect of chewing gum on tobacco withdrawal. Poster presented at the Association for the Behavioral Sciences and Medical Education Conference; 1999. [abstract] Ann Behav Med. 1999; 21(Suppl):S039.

Stetson B, Dubbert P, Rahn J, Wilner B, Mercury M, Britt (DiBenedetti) D. Gender differences in the cognitive appraisal of exercise relapse. Poster presented at the 1993 Society of Behavioral Medicine Conference; 1993. [abstract] Ann Behav Med. 1993 Jun 1; 15(2-3):S167. doi: 10.1093/abm/15.2-3.164

Stetson B, Dubbert P, Wilner B, Rahn J, Mercury M, Britt (DiBenedetti) D. Influence of biological and psychosocial factors on activity in free-exercising adults. Poster presented at the 1993 Society of Behavioral Medicine Conference; 1993. [abstract] Ann Behav Med. 1993; 15(Suppl):S167.

Smith PO, Stetson B, Dubbert P, Mercury M, Rahn J, Britt (DiBenedetti) DM. Body image differences in adult exercising women. Poster presented at the 1993 Society of Behavioral Medicine Conference; 1993. [abstract] Ann Behav Med. 1993; 15(Suppl):S167.